Treatment: Other T Cell-Related Primary Immunodeficiencies

Treatment is complex and largely investigational. HSCT plays a role in some diseases. Live vaccines and blood transfusions containing viable T cells should be strictly avoided. Prophylaxis for P. jirovecii pneumonia should be considered in selected pts with severe T-cell deficiency.